Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Juno stock drops on report of lackluster immunotherapy results on solid tumors
Juno stock drops on report of lackluster immunotherapy results on solid tumors
Juno stock drops on report of lackluster immunotherapy results on solid tumors
Submitted by
admin
on April 20, 2015 - 5:23pm
Source:
Bizjournals.com
News Tags:
Juno Therapeutics
solid tumors
Novartis
Headline:
Juno stock drops on report of lackluster immunotherapy results on solid tumors
Do Not Allow Advertisers to Use My Personal information
